METHOD FOR CONSTRUCTING CIRCULAR RNA AND VACCINE AGAINST FIPV

MULTIVALENT CARRIERS AND RELATED VACCINE COMPOSITIONS

COMPOSITIONS INCLUDING SBI ADJUVANTS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR DELIVERY OF RNA

ANTIGEN SPECIFIC IMMUNOTHERAPY FOR COVID-19 FUSION PROTEINS AND METHODS OF USE

MULTI-EPITOPE CONSTRUCT

RNA RECOGNITION COMPLEX AND USES THEREOF

ALPHAVIRUS REPLICON ENCODING CHIMERIC SARS-COV-2 RECEPTOR BINDING DOMAINS

METHODS FOR PROVIDING PROTECTION TO PORCINE EPIDEMIC DIARRHEA VIRUS (PEDV) WITH A PLANT PRODUCED VACCINE

DETECTION AGENT, DETECTION SYSTEM AND METHOD THEREOF

PORCINE EPIDEMIC DIARRHEA VIRUS STRAINS AND IMMUNOGENIC COMPOSITIONS THEREFROM

IMMUNOGENIC AND VACCINE COMPOSITIONS AGAINST SARS-CoV-2

COMPOSITIONS AND METHODS FOR DELIVERY OF RNA

STABLE CORONAVIRUS PROTEINS AND VACCINE COMPOSITIONS THEREOF

Vaccine Compositions For Preventing Coronavirus Disease

SELF-ASSEMBLING INSECT FERRITIN NANOPARTICLES

DJUVANTED PROTEIN VACCINES COMPRISING MODIFIED FULL-LENGTH SPIKE PROTEIN OF SARS-COV-2 COMPOSITION AND METHODS OF USE

METHODS AND COMPOSITIONS FOR TREATMENT OF VIRAL INFECTION

METHOD FOR PREPARING AND CERTIFYING NOVEL CORONAVIRUS NUCLEOCAPSID PROTEIN

COPOLYMER, ANTIBODY-COPOLYMER CONJUGATE PREPARATION KIT, ANTIBODY-COPOLYMER CONJUGATE, METHOD FOR CONCENTRATING ANTIGEN, AND METHOD FOR DETECTING ANTIGEN

Nucleic acid base vaccine against emerging SARS-CoV-2 variants

Compositions and methods for delivery of RNA

MERS CORONAVIRUS VACCINE

COMPOSITIONS INCLUDING SBI ADJUVANTS AND METHODS OF USE THEREOF

MESSENGER RNA VACCINES AGAINST WIDE SPECTRUM OF CORONAVIRUS VARIANTS

HIGH THROUGHPUT METHODS AND PRODUCTS FOR SARS-COV-2 SERO-NEUTRALIZATION ASSAY

COMPOSITIONS IMMUNOGENIC AGAINST INFLUENZA AND SARS CORONAVIRUS 2, METHODS OF MAKING AND USING THEREOF

METHODS AND SYSTEMS FOR DETECTION AND ANALYSIS OF ANGIOTENSIN BINDING ANTIBODIES

IDENTIFICATION OF SARS-COV-2 EPITOPES DISCRIMINATING COVID-19 INFECTION FROM CONTROL AND METHODS OF USE

Adenoviral vector not including replication competent adenovirus, and use thereof

IMMUNOGENIC FORMULATION CONTAINING ONE OR MORE MODIFIED BCG STRAINS EXPRESSING A SARS-CoV-2 PROTEIN, USEFUL FOR PREVENTING, TREATING, OR ATTENUATING THE DEVELOPMENT OF COVID-19

YEAST-BASED EXPRESSION OF THERAPEUTIC PROTEINS IN VIVO

Vaccine composition for prevention or treatment of SARS-coronavirus-2 infection

METHOD FOR PRODUCING VIRUS

METHODS FOR MODULATING HOST CELL SURFACE INTERACTIONS WITH SARS-COV-2

Vaccine booster compositions for respiratory viral diseases

MULTICISTRONIC RNA VACCINES AND USES THEREOF

ANTIGEN SPECIFIC IMMUNOTHERAPY FOR COVID-19 FUSION PROTEINS AND METHODS OF USE

IMMUNITY AND PROTECTION OF SARS-COV-2 DNA AND PROTEIN VACCINE

INTRADERMAL MERS-CoV VACCINE

DNA ENCODED NANOPARTICLES AND METHOD OF USE THEREOF AS A CORONAVIRUS DISEASE 2019 (COVID-19) VACCINE

METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING VIRAL INFECTION

BROAD-SPECTRUM PEPTIDE ANTIGEN OF THE NOVEL CORONAVIRUS SARS-COV-2, SPECIFIC NEUTRALIZING ANTIBODY AND USE THEREOF

Immunogenic Coronavirus Fusion Proteins and Related Methods

METHOD AND KIT FOR DETECTION OF CELL MEDIATED IMMUNE RESPONSE

WW-DOMAIN-ACTIVATED EXTRACELLULAR VESICLES TARGETING CORONAVIRUSES

GENETICALLY ENGINEERED DENDRITIC CELLS TO ACTIVATE PROTEIN SPECIFIC T CELLS FOR THE TREATMENT OF VIRAL AND OTHER PATHOGENIC INFECTIONS

BETA CORONAVIRUS COLD ACCLIMATIZED STRAIN AND VACCINE

METHODS FOR CONTROL OF AN INFECTIVE DISEASE WITH A VACCINE

Compositions and methods for delivery of RNA

Assay for the detection of the Cys-like protease (Mpro) of SARS-CoV-2

ANTIGEN FOR 2019 NOVEL CORONAVIRUS AND DETECTION USE THEREOF

COMBINED USE OF NANOBODY, CYCLODEXTRIN AND QUERCETIN FOR PROTECTION FROM ENVELOPED VIRUSES

SARS-CoV-2 PROTEIN-DERIVED PEPTIDE AND VACCINE CONTAINING SAME

VACCINE COMPOSITIONS FOR MUCOSAL IMMUNE RESPONSE

Immunogenic Compositions Against SARS-COV-2 Variants And Their Methods Of Use

Novel Coronavirus Testing

IMMUNOGENS DERIVED FROM SARS-COV2 SPIKE PROTEIN

PHOSPHATE-REGULATED EXPRESSION OF BIOLOGICALLY ACTIVE RECOMBINANT CORONAVIRUS GLYCOPROTEINS AND OTHER RECOMBINANT PROTEINS IN PHAEODACTYLUM TRICORNUTUM

MRNA OR MRNA COMPOSITION, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

OMICRON SARS-COV-2 ASSAY

Methods for the treatment of COVID-19 comprising administering replication-defective adenoviruses encoding the SARS-CoV-2 spike glycoprotein and modified nucleocapsid protein

RECOMBINANT VACCINIA VIRUS

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING CORONAVIRUSES

Germicidal UV light device

COVID ASSAY CONTROLS

VACCINE COMPOSITION FOR PREVENTING SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 INFECTION

VACCINE COMPOSITION FOR PREVENTING OR TREATING INFECTION OF SARS-COV-2

Identification of inhibitor peptides to bind with N-terminal Spike (S) and nonstructural protein (NSP) sequences of SARS-COV2 B.1.617.2 Delta or Omicron variants alone and combination with drug(s) for targeted antiviral therapy

CHIMERIC RSV AND CORONAVIRUS PROTEINS, IMMUNOGENIC COMPOSITIONS, AND METHODS OF USE

MONO- AND MULTI-VALENT SARS-COV- 2 ADENOVIRAL VECTOR VACCINES AND SARS-COV-2 IMMUNE GLOBULIN AND METHODS OF USE

MODIFIED BETACORONAVIRUS SPIKE PROTEINS

CORONAVIRUS VACCINE CONSTRUCTS AND METHODS OF MAKING AND USING SAME

CELL-MEDIATED SARS-COV-2 VACCINES, AND PREPARATION AND USE THEREOF

ACETYLCHOLINE MODULATION OF IMMUNE FUNCTION

RNA VACCINES

MODIFIED ALPHAVIRUS FOR USE AS COVID-19 VACCINE

ENGINEERED BACTERIA FOR USE IN VACCINE COMPOSITIONS

VACCINE COMBINATION AGAINST SARS-COV-2 AND METHOD FOR PREVENTING INFECTION OF SARS-COV-2

SAFE POTENT SINGLE VECTOR PLATFORM VACCINE AGAINST COVID-19

PEPTIDE FOR SUPPRESSING CORONAVIRUS AND USE THEREOF

DETECTION REAGENT FOR SCREENING BLOCKING AGENT OF CORONAVIRUS INFECTIONS, AND DETECTION METHOD

SARS-CORONAVIRUS 2 (SARS-COV-2) SUBUNIT VACCINE CANDIDATES

MULTI-EPITOPE PAN-CORONAVIRUS VACCINE COMPOSITIONS

MODIFIED MRNAS FOR VACCINE DEVELOPMENT

Compositions and methods for delivery of RNA

Compositions and methods for delivery of RNA

Engineered Alum-binding SARS-CoV-2 Immunogens

Compositions and methods for delivery of RNA

COMPOSITIONS IMMUNOGENIC AGAINST SARS CORONAVIRUS 2, METHODS OF MAKING, AND USING THEREOF

Systems and methods for the preparation of vaccines utilizing predictably inactivated pathogens

Rapid assay for detection of SARS-CoV-2 antibodies

CORONAVIRUS VACCINES AND USES THEREOF

Compositions and methods for delivery of RNA

SARS-COV-2 RECOMBINANT RBD PROTEIN, AND PREPARATION METHOD THEREFOR

Compositions and methods for delivery of RNA

Compositions including SBI adjuvants and methods of use thereof

RECOMBINANT PROTEINS, COMPOSITIONS, VECTORS, KITS, AND METHODS FOR IMMUNIZING AGAINST, AND TESTING FOR EXPOSURE TO, SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2

MULTIVALENT PARTICLES COMPOSITIONS AND METHODS OF USE

Stable coronavirus proteins and vaccine compositions thereof

SARS-CoV-2 SPIKE ECTODOMAIN POLYPEPTIDES AND COMPOSITIONS AND METHODS THEREOF

Nucleic acid-small diameter and liquid core nanoparticle complexed compositions

Immunogenic and vaccine compositions against SARS-CoV-2

Synthetic plasmid DNA vaccine expressing a codon-optimized SARS-COV-2 spike protein

RECOMBINANT POLYPEPTIDES CONTAINING AT LEAST ONE IMMUNOGENIC FRAGMENT AND USES THEREOF

ACETYLCHOLINE MODULATION OF IMMUNE FUNCTION

CLEAVING PRE-FUSION STATE SARS-COV-2 SPIKE PROTEIN

Rapid assay for detection of SARS-CoV-2 antibodies

MULTIVALENT CARRIERS AND RELATED VACCINE COMPOSITIONS

NEUTRALIZING VACCINES AGAINST HUMAN CORONAVIRUS

Multivalent particles compositions and methods of use

SARS-CoV-2 antigens and uses thereof

SYNTHETIC PEPTIDES, AMINO-ACID SEQUENCES, AND COMPOSITIONS USEFUL FOR SARS-CoV-2 DETECTION AND COVID-19 PREVENTION

SARS-COV2 spike peptides that interact with HLA-DR1 and human TLR8

CORONAVIRUS-TARGETING UNIVERSAL DC CELL VACCINE, AND PREPARATION METHOD AND USE THEREOF

Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use

Porcine epidemic diarrhea virus strains and immunogenic compositions therefrom

Cleaving pre-fusion state SARS-CoV-2 spike protein

EMULSOMES COMPRISING S-LAYER FUSION PROTEINS AND METHODS OF USE THEREOF

ANTI COVID-19 THERAPIES USING NUCLEOCAPSID AND SPIKE PROTEINS

Method of inducing immunity against SARS-CoV-2 using spike and nucleocapsid-ETSD immunogens delivered by RNA and replication-defective adenoviruses

Methods and compositions for treating and preventing viral infection

ACE2-Fc FUSION PROTEINS FOR SARS-COV-2 MITIGATION

Binding agents to pre-fusion state SARS-CoV-2 spike protein

MERS coronavirus vaccine

ALIMENTARY AND SYSTEMIC ANTIVIRAL THERAPEUTICS

SARS-COV-2 antigen polypeptide, recombinant adeno-associated virus expressing the polypeptide, and vaccine containing the virus

SARS-CoV-2 Vaccines

Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use

SARS-COV-2 N PROTEIN AND METHODS OF USE

Replication-competent attenuated chimeric VSV vectors encoding immunogenic SARS-CoV-2 spike proteins

Alphavirus replicon encoding chimeric SARS-CoV-2 receptor binding domains

COMPOSITIONS AND METHODS FOR DRUG DELIVERY AND TREATING VIRAL INFECTIONS

Immunogenic composition against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

SARS-CoV-2 surrogate virus neutralization assay test kit

Replication-defective adenoviruses comprising nucleic acids encoding SARS-CoV-2 s glycoprotein and modified N protein comprising an endosomal targeting sequence

LICHENASE-COVID-19 BASED VACCINE

Immunogenic and vaccine compositions against SARS-CoV-2

Coronavirus-targeting universal DC cell vaccine, and preparation method and use thereof

PD-1-based vaccines against coronavirus infection

Self-assembling insect ferritin nanoparticles

MULTIEPITOPE FUSION ANTIGENS FOR VACCINATION AND METHODS OF MAKING AND USING SUCH ANTIGENS

Human Antibodies to Middle East Respiratory Syndrome - Coronavirus Spike Protein

MERS coronavirus vaccine

Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens

Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use

Recombinant spike ectodomain proteins, compositions, vectors, kits, and methods for immunizing against avian infectious bronchitis virus

PORCINE EPIDEMIC DIARRHEA VIRUS VACCINES AND METHODS OF USE THEREOF

Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use

Porcine epidemic diarrhea virus vaccine

Porcine epidemic diarrhea virus strains and immunogenic compositions therefrom

Adaptation of attenuated infectious bronchitis virus (IBV) to embryonic kidney cells and vaccine thereby produced

Human antibodies to Middle East Respiratory Syndrome—coronavirus spike protein

Vaccine for use in protecting a pig against porcine epidemic diarrhea virus

Porcine epidemic diarrhea virus vaccines and methods of use thereof

Adaptation of attenuated infectious bronchitis virus (IBV) to embryonic kidney cells and vaccine thereby produced

Mutant spike protein extending the tissue tropism of infectious bronchitis virus (IBV)

Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using

Methods for producing and using IgY antibodies targeting the middle east respiratory syndrome coronavirus spike protein to treat or prevent MERS-CoV infection

Rapid assay for detection of SARS-CoV-2 antibodies

Molecules that bind to SARS-CoV-2